Latest Advances in Lung Cancer Research

Moffitt Cancer Center seeks federal funding for a mobile unit to improve lung cancer screening rates, especially for marginalized communities, aiming for operational status by early 2024.

Medicare expands LDCT lung cancer screening eligibility, lowering age to 50 and pack-year history to 20, streamlining processes to improve early detection.

Mount Sinai study shows earlier lung cancer diagnosis via CT screening significantly reduces deaths, underscoring the need for widespread screening adherence.

Artificial intelligence blood test to detect lung cancer. Researchers developed novel technology to detect lung cancer in patients.

Address disparities in lung cancer screening. Abstracts presented at ASCO’s 2021 annual meeting address disparities in lung cancer screening.

Lower risk of brain mets from screening. LDCT Screening linked to lower risk of brain mets for lung cancer patients.

Latest in depth analysis and recommendations for lung cancer screening from the United States Preventive Services Task Force

Why are lung cancer deaths in non-smokers on the rise? The proportion of non-smoker lung cancer patients jumped from 8% in 1990 to 15% in 2013.

Genetics influence SCLC risk: The genetic factors that influence small cell lung cancer risk have not received a great deal of attention from scientists.

Exploring saliva in early lung cancer detection: UCLA School of Dentistry researchers are looking at saliva for its diagnostic possibilities.

Lung cancer in never smokers is becoming more prominent – especially in women. 12% of U.S. lung cancer patients are never-smokers and it is increasing.

Lung cancer screenings down due to COVID. Drop in lung cancer screenings due to canceled or postponed services has led to worse patient outcomes.